LabConnect Selects Johnson City, Tennessee for its New Headquarters

April 2, 2020, JOHNSON CITY, TN – LabConnect today announced the relocation of its official headquarters from Seattle, WA, to Johnson City, TN. In collaboration with the State of Tennessee, Northeast Tennessee Regional Economic Partnership (NeTREP), and Tennessee Valley Authority (TVA), LabConnect will further invest to support the company’s significant growth.

“LabConnect is unique in the market and integral to the development of important new drugs. Johnson City, TN is an ideal community to support our steep growth in the US and Internationally and we are excited to expand our facility, where we currently have 200 employees”, said Tom Sellig, LabConnect’s Chief Executive Officer. “The area offers benefits of local universities for recruitment, a lower cost of living with a high quality of life, and a hard-working, loyal workforce. Tennessee officials have been very welcoming, and we anticipate a great relationship going forward as we scale the organization.”

LabConnect, a leading provider of clinical services plans to invest in continued infrastructure improvements, expanding LabConnect’s clinical kit building capability, doubling its biorepository capacity, and other modifications to the Johnson City facility. The company is projecting significant job growth and expects to double the number of employees over the next few years. LabConnect’s partnership with these Tennessee organizations will position the company as a top employer of the region while creating exciting career growth opportunities.

Founded 18 years ago, LabConnect has become a leader in providing laboratory services for clinical trials all around the world. The company is pleased to have chosen Tennessee as its official location while continuing to maintain a global network of sites, sponsors, and resources.

About LabConnect

LabConnect improves lives by partnering with pharmaceutical and biotechnology companies, contract research organizations (CROs), and foundations/non-governmental organizations (NGOs), to accelerate the development of new medicines around the world. LabConnect delivers a unique combination of support services through Central Laboratory Services and Functional Service Provider (FSP) Solutions that are tailor-made, timely and flexible to meet the evolving study demands of traditional to increasingly complex clinical trials. Visit us at LabConnect.com.

Media Contacts

Jean Marie Thompson, SVP Marketing, LabConnect jmthompson@labconnect.com